Linkedin
Sign in
Join
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
X
Subscribe
Subscribe
Facebook
Linkedin
X
Youtube
Hot topics
Is Your Field Force Sales Enabled? Are They Sales Ready?
0
Pankaj Gurusahani and Arun Subramanian, Co-founder of Enparadigm with...
Made in China Biotech Is Shaking Up Global Drug Innovation
0
The era of Chinese biotech as a mere imitator...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
0
In a bold move to strengthen its hepatology pipeline,...
What about Indian Pharma?
0
Articles by K. Hariram, Vivek Hattangadi, Soham Wagh, Dr. Rajshri Jobanputra, and Rashesh Patel
Novo Nordisk — Septerna’s $2.2 Billion Deal
0
A New Era for Obesity Pills Novo Nordisk has announced...
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Hot topics
FLUX – Indian Pharma in the Post VUCA World
0
Introduction For decades, leaders and organizations have relied on the...
Partner Don’t Punish
0
Articles by Vivek Hattangadi, Genesh Kuriakose, Pankaj Mehrotra, Salil Kallianpur and Jay Mehta
Breaking Performance Barriers
0
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
Debasish Banerjee’s Journey from Medical Rep to Chief Compliance Officer
0
For a person wanting to be a doctor, my...
Executive Compensation in Pharma Companies in India: MNCs vs Indian Firms
0
The pharmaceutical industry in India is a rapidly evolving...
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Home
DSC_6751
DSC_6751
DSC_6751
